Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
Nordsjællands Hospital, Hillerød, Danmark, Denmark
University of Rzeszow, Rzeszów, Poland
Szpital Specjalistyczny PRO-FAMILIA w Rzeszowie, Rzeszów, Poland
Szpital Kliniczny Dzieciątka Jezus, Warszawa, Poland
Stanford University, Stanford, California, United States
The Christ Hospital, Cincinnati, Ohio, United States
AZ KLina, Brasschaat, Antwerp, Belgium
University Hospital Antwerp, Edegem, Antwerp, Belgium
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
UAB Department of Anesthesiology and Perioperative Medicine, Birmingham, Alabama, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.